RadioRx
Executives
2Board of Directors
2RadioRx Management Team
2 Team Members
RadioRx has 2 executives. RadioRx's former Chief Executive Officer, President is John Santini.
Name | Work History | Title | Status |
|---|---|---|---|
John Santini | Chief Executive Officer, President | Former | |
Name | John Santini | |
|---|---|---|
Work History | ||
Title | Chief Executive Officer, President | |
Status | Former |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
RadioRx Board of Directors
2 Board of directors
RadioRx has 2 board of directors, including Arnold Oronsky.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
Arnold Oronsky | Arnie Oronsky, Ph.D. is a founder and board member of Centrexion Therapeutics. Arnie currently serves as a general partner and managing director at InterWest Partners LLC, a venture capital firm. Earlier in his career, Arnie led pharmaceutical research as vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company. He is a board member of Applied Genetic Technologies Corporation, Drais Pharmaceuticals, Dynavax Technologies, EpicentRx, Integrated Diagnostics, PMV Pharma, Potenza Therapeutics, Sera Prognostics, TESARO and Tizona Therapeutics. Arnie holds a B.A. degree from New York University, a Ph.D. in Immunology from Columbia University and is a senior lecturer at Johns Hopkins Medical School. | RadioRx | |
Gordon Saul | Gordon Saul joined InterWest's life sciences team in 2003 and currently holds operating roles in two InterWest portfolio companies: founder, chief business officer and chief financial officer of Carbylan BioSurgery | RadioRx |
Name | Arnold Oronsky | Gordon Saul |
|---|---|---|
Firm | ||
Work History | Arnie Oronsky, Ph.D. is a founder and board member of Centrexion Therapeutics. Arnie currently serves as a general partner and managing director at InterWest Partners LLC, a venture capital firm. Earlier in his career, Arnie led pharmaceutical research as vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company. He is a board member of Applied Genetic Technologies Corporation, Drais Pharmaceuticals, Dynavax Technologies, EpicentRx, Integrated Diagnostics, PMV Pharma, Potenza Therapeutics, Sera Prognostics, TESARO and Tizona Therapeutics. Arnie holds a B.A. degree from New York University, a Ph.D. in Immunology from Columbia University and is a senior lecturer at Johns Hopkins Medical School. | Gordon Saul joined InterWest's life sciences team in 2003 and currently holds operating roles in two InterWest portfolio companies: founder, chief business officer and chief financial officer of Carbylan BioSurgery |
Other Seats | RadioRx | RadioRx |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Loading...